Benzene
Benzene is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Benzene
Benzene is a six-carbon aromatic annulene in which each carbon atom donates one of its two 2p electrons into a delocalised system. A toxic, flammable liquid byproduct of coal distillation, it is used as an industrial solvent. Benzene is a carcinogen that also damages bone marrow and the central nervous system. It has a role as a non-polar solvent, a carcinogenic agent and an environmental contaminant. It is a volatile organic compound, a member of benzenes and an aromatic annulene. — ChEBI
- IUPAC name
- benzene
- Molecular formula
- C6H6
- Molecular weight
- 78.11 g/mol
- Exact mass
- 78.0469501914 Da
- XLogP3
- 2.1
- Topological polar surface area
- 0.0 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 0
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:16716
- ChEMBL:CHEMBL277500
- EPA DTXSID:DTXSID3039242
- PubMed:40885242
- PubMed:40854414
- PubMed:39842622
- PubMed:39357595
- PubMed:38914192
- PubMed:38866309
- PubMed:38367942
- PubMed:38070821
- PubMed:37084897
- PubMed:36436547
- PubMed:36416909
- PubMed:36306860
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Benzene
Regulatory information
Other directives
(EC) 2009/552 - as a constituent of other substances, or in mixtures, in concentrations equal to, or greater than 0.1% by weight
CMR
| Category | Carcinogenic | Mutagenic | Reprotoxic |
|---|---|---|---|
| Cat. 1A | ✓ | — | — |
| Cat. 1B | — | ✓ | — |
Key data
Related records for Benzene
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Barium salts, with the exception of barium sulphide under the conditions laid down in Annex III and…
Atropine, its salts and derivatives
Atropa belladonna L. and its preparations
1-Dimethylaminomethyl-1-methylpropyl benzoate (amylocaine) and its salts
2,2,6-Trimethyl-4-piperidyl benzoate (eucaine) and its salts
Apomorphine ((R)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol)) and its salts
Apocynum cannabium L. and its preparations
Bendroflumethiazide (INN) and its derivatives
What Annex II means for Benzene
Benzene is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
- This substance has CMR classification. Review the CMR table above and verify current Annex II/III status before use.
Frequently asked questions
Source note for Annex II record Benzene
This page summarizes one Annex II record for Benzene from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Benzene, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Benzene and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Benzene side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II